U.S. Markets closed

Personalis to Present at Upcoming Investor Conferences

MENLO PARK, Calif.--(BUSINESS WIRE)--

Personalis, Inc. (Nasdaq: PSNL), a leader in advanced genomics for cancer, today announced that Aaron Tachibana, Chief Financial Officer and Clinton Musil, Chief Business Officer, are scheduled to present at the following upcoming investor conferences.

  • Piper Jaffray 31st Annual Healthcare Conference on Wednesday, December 4, 2019 at 11:30 a.m. Eastern Time at the Lotte New York Palace Hotel in New York.
  • Evercore ISI 2nd Annual HealthCONx Conference on Thursday, December 5, 2019 at 11:00 a.m. Eastern Time at the Four Seasons Hotel in Boston.

About Personalis, Inc.

Personalis, Inc. is a growing cancer genomics company transforming the development of next-generation therapies by providing more comprehensive molecular data about each patient’s cancer and immune response. The company’s NeXT™ Platform is designed to adapt to the complex and evolving understanding of cancer, providing its biopharmaceutical customers with information on all of the approximately 20,000 human genes, together with the immune system, from a single tissue sample. Personalis also provides genomic information to the VA Million Veterans Program as part of their goal to sequence over a million veteran genomes. The Personalis Clinical Laboratory is GxP aligned as well as CLIA’88-certified and CAP-accredited. For more information, please visit www.personalis.com and follow Personalis on Twitter (@PersonalisInc).

View source version on businesswire.com: https://www.businesswire.com/news/home/20191119005053/en/